Bayesian analysis of a disability model for lung cancer survival

Bayesian reasoning, survival analysis and multi-state models are used to assess survival times for Stage IV non-small-cell lung cancer patients and the evolution of the disease over time. Bayesian estimation is done using minimum informative priors for the Weibull regression survival model, leading to an automatic inferential procedure. Markov chain Monte Carlo methods have been used for approximating posterior distributions and the Bayesian information criterion has been considered for covariate selection. In particular, the posterior distribution of the transition probabilities, resulting from the multi-state model, constitutes a very interesting tool which could be useful to help oncologists and patients make efficient and effective decisions.

[1]  Y. Soon,et al.  Duration of chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Jim Albert,et al.  Bayesian Computation with R , 2008 .

[3]  A. F. Stewart Hypercalcemia Associated with Cancer , 2005 .

[4]  N. Keiding,et al.  Multi-state models for event history analysis , 2002, Statistical methods in medical research.

[5]  Maja Pohar Perme,et al.  Inference for outcome probabilities in multi-state models , 2008, Lifetime data analysis.

[6]  V T Farewell,et al.  A multi‐state model for joint modelling of terminal and non‐terminal events with application to Whitehall II , 2007, Statistics in medicine.

[7]  E. Brambilla,et al.  The evolving role of histology in the management of advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J P Klein,et al.  Multi‐state models and outcome prediction in bone marrow transplantation , 2001, Statistics in medicine.

[9]  N. Malats,et al.  A dynamic model for the risk of bladder cancer progression , 2012, Statistics in medicine.

[10]  P Hougaard,et al.  Multi-state Models: A Review , 1999, Lifetime data analysis.

[11]  L. Sharples,et al.  Predicting Survival in Potentially Curable Lung Cancer Patients , 2008, Lung.

[12]  G. Schwarz Estimating the Dimension of a Model , 1978 .

[13]  A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer , 2005, British Journal of Cancer.

[14]  Ardo van den Hout,et al.  Multi‐state analysis of cognitive ability data: A piecewise‐constant model and a Weibull model , 2008, Statistics in medicine.

[15]  I. G. Evans,et al.  Bayesian prediction for two-parameter weibull lifetime models , 1980 .

[16]  A. Raftery,et al.  Bayesian Information Criterion for Censored Survival Models , 2000, Biometrics.

[17]  B. Jeremic,et al.  Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy , 2003, Journal of Cancer Research and Clinical Oncology.

[18]  R. Doll The Age Distribution of Cancer: Implications for Models of Carcinogenesis , 1971 .

[19]  J. Klein,et al.  Survival Analysis: Techniques for Censored and Truncated Data , 1997 .

[20]  Thomas Kneib,et al.  Bayesian semi parametric multi-state models , 2008 .

[21]  Arnold Knijn,et al.  EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. , 2009, European journal of cancer.

[22]  J. Berger The case for objective Bayesian analysis , 2006 .

[23]  K. Eguchi,et al.  Hypercalcemia-leukocytosis syndrome associated with lung cancer. , 2004, Lung cancer.

[24]  A. Rossi,et al.  The emerging role of histology in the choice of first-line treatment of advanced non-small cell lung cancer: implication in the clinical decision-making. , 2010, Current medicinal chemistry.

[25]  D Oakes,et al.  Multiple time scales in survival analysis , 1995, Lifetime data analysis.

[26]  Yohann Foucher,et al.  A semi-Markov model for multistate and interval-censored data with multiple terminal events. Application in renal transplantation. , 2007, Statistics in medicine.

[27]  J. Klein,et al.  Statistical Models Based On Counting Process , 1994 .

[28]  Ardo van den Hout,et al.  Estimating dementia-free life expectancy for Parkinson's patients using Bayesian inference and microsimulation , 2009, Biostatistics.

[29]  Peter Green,et al.  Markov chain Monte Carlo in Practice , 1996 .

[30]  Joseph G. Ibrahim,et al.  Bayesian Survival Analysis , 2004 .

[31]  Michael C. Minnotte,et al.  Noncancer deaths in white adult cancer patients. , 1993, Journal of the National Cancer Institute.

[32]  Michael J Pencina,et al.  Choice of time scale and its effect on significance of predictors in longitudinal studies , 2007, Statistics in medicine.

[33]  Carmen Cadarso-Suárez,et al.  Multi-state models for the analysis of time-to-event data , 2009, Statistical methods in medical research.

[34]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.